CVS Health Co. (NYSE:CVS) Shares Sold by Douglas Lane & Associates LLC

Douglas Lane & Associates LLC lessened its holdings in CVS Health Co. (NYSE:CVS) by 40.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 690,096 shares of the pharmacy operator’s stock after selling 462,101 shares during the quarter. Douglas Lane & Associates LLC owned 0.05% of CVS Health worth $30,978,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health in the third quarter valued at $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the 3rd quarter worth $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the third quarter valued at about $31,000. Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new position in CVS Health during the third quarter worth about $33,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the topic of several research analyst reports. Piper Sandler decreased their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Mizuho lowered their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Barclays cut their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Royal Bank of Canada dropped their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Finally, Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Trading Up 0.3 %

CVS Health stock traded up $0.12 during trading on Wednesday, reaching $45.90. The company had a trading volume of 7,476,451 shares, compared to its average volume of 11,352,654. The firm has a market capitalization of $57.76 billion, a price-to-earnings ratio of 11.65, a PEG ratio of 0.85 and a beta of 0.59. The stock’s 50 day moving average price is $52.40 and its two-hundred day moving average price is $56.86. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $81.03. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.21 EPS. As a group, equities analysts expect that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 5.80%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.